Connection
Mark Lovell to Nerve Tissue Proteins
This is a "connection" page, showing publications Mark Lovell has written about Nerve Tissue Proteins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.751 |
|
|
|
-
Bradley-Whitman MA, Lovell MA. Epigenetic changes in the progression of Alzheimer's disease. Mech Ageing Dev. 2013 Oct; 134(10):486-95.
Score: 0.335
-
Lovell MA, Markesbery WR. Ectopic expression of Musashi-1 in Alzheimer disease and Pick disease. J Neuropathol Exp Neurol. 2005 Aug; 64(8):675-80.
Score: 0.191
-
Lovell MA, Soman S, Bradley MA. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech Ageing Dev. 2011 Aug; 132(8-9):443-8.
Score: 0.073
-
Markesbery WR, Lovell MA. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol. 2007 Jul; 64(7):954-6.
Score: 0.055
-
Lovell MA, Geiger H, Van Zant GE, Lynn BC, Markesbery WR. Isolation of neural precursor cells from Alzheimer's disease and aged control postmortem brain. Neurobiol Aging. 2006 Jul; 27(7):909-17.
Score: 0.047
-
Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging. 1997 Sep-Oct; 18(5):457-61.
Score: 0.028
-
Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 1994 Jun 01; 54(11):2869-72.
Score: 0.022